Protein catabolism in rat liver homogenates. A re-evaluation of the energy requirement for protein catabolism.
D000409:Alanine / Q000494:pharmacology; D000596:Amino Acids / Q000378:metabolism; D000818:Animals; D001151:Arsenic / Q000494:pharmacology; D001386:Azides / Q000494:pharmacology; D002247:Carbon Isotopes; D002614:Chelating Agents / Q000494:pharmacology; D011232:Chemical Precipitation; D002701:Chloramphenicol / Q000494:pharmacology; D003486:Cyanides / Q000494:pharmacology; D003513:Cycloheximide / Q000494:pharmacology; D003851:Deoxyribonucleases / Q000494:pharmacology; D004140:Dinitrophenols / Q000494:pharmacology; D004735:Energy Transfer; D006358:Hot Temperature; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D007531:Isoflurophate / Q000494:pharmacology; D007700:Kinetics; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D008239:Lysine / Q000378:metabolism; D008297:Male; D008660:Metabolism / Q000187:drug effects; D009840:Oligomycins / Q000494:pharmacology; D010100:Oxygen / Q000494:pharmacology; D010649:Phenylalanine / Q000378:metabolism; D011489:Protein Denaturation; D011506:Proteins / Q000378:metabolism*; D011691:Puromycin / Q000494:pharmacology; D051381:Rats; D012260:Ribonucleases / Q000494:pharmacology; D013438:Sulfhydryl Compounds / Q000037:antagonists & inhibitors; D014361:Trypsin Inhibitors / Q000494:pharmacology
D000596:Amino Acids; D001386:Azides; D002247:Carbon Isotopes; D002614:Chelating Agents; D003486:Cyanides; D004140:Dinitrophenols; D009840:Oligomycins; D011506:Proteins; D013438:Sulfhydryl Compounds; D014361:Trypsin Inhibitors; D007531:Isoflurophate; D010649:Phenylalanine; D011691:Puromycin; D002701:Chloramphenicol; D003513:Cycloheximide; D003851:Deoxyribonucleases; D012260:Ribonucleases; D008239:Lysine; D001151:Arsenic; D000409:Alanine; D010100:Oxygen